CA2282234A1 - Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug - Google Patents

Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug Download PDF

Info

Publication number
CA2282234A1
CA2282234A1 CA002282234A CA2282234A CA2282234A1 CA 2282234 A1 CA2282234 A1 CA 2282234A1 CA 002282234 A CA002282234 A CA 002282234A CA 2282234 A CA2282234 A CA 2282234A CA 2282234 A1 CA2282234 A1 CA 2282234A1
Authority
CA
Canada
Prior art keywords
mushroom
crude drug
antitumor activity
antitumor
far infrared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002282234A
Other languages
English (en)
French (fr)
Inventor
Kozo Niwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2282234A1 publication Critical patent/CA2282234A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
CA002282234A 1998-09-17 1999-09-16 Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug Abandoned CA2282234A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP10-263753 1998-09-17
JP26375398 1998-09-17
JP10-323374 1998-11-13
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (1)

Publication Number Publication Date
CA2282234A1 true CA2282234A1 (en) 2000-03-17

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002282234A Abandoned CA2282234A1 (en) 1998-09-17 1999-09-16 Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug

Country Status (19)

Country Link
JP (1) JP2000159682A (nl)
KR (1) KR20000023206A (nl)
CN (1) CN1255376A (nl)
AU (1) AU4486299A (nl)
BE (1) BE1012725A5 (nl)
CA (1) CA2282234A1 (nl)
DE (1) DE19944695A1 (nl)
DK (1) DK199901235A (nl)
ES (1) ES2155802B1 (nl)
FR (2) FR2783426A1 (nl)
GB (2) GB9920710D0 (nl)
ID (1) ID23150A (nl)
IL (1) IL131722A0 (nl)
IS (1) IS5183A (nl)
IT (1) IT1307267B1 (nl)
NL (2) NL1013049C2 (nl)
NO (1) NO994463L (nl)
SE (2) SE9903307L (nl)
SG (1) SG76631A1 (nl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354355T1 (de) * 2001-04-27 2007-03-15 Ajinomoto Kk Eine dispersion aus beta-glukan enthaltenden hochfeinen partikel, ein entsprechender herstellungsprozess und die verwendung der dispersion
CN1320121C (zh) * 2001-05-07 2007-06-06 拜奥哈步株式会社 制备蘑菇乳酸发酵溶液的方法及由此制备的蘑菇乳酸发酵溶液
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
JP4561098B2 (ja) * 2001-06-01 2010-10-13 味の素株式会社 糖尿病用薬剤
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
KR100971599B1 (ko) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 혈관 관련 질환의 예방 또는 치료를 위한 조성물
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
JP5034071B2 (ja) * 2004-09-17 2012-09-26 株式会社Ｓ・Ｓ・Ｉ 乳癌を抑制するカワリハラタケ抽出物
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
WO2011081024A1 (ja) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
WO2019104579A1 (en) * 2017-11-30 2019-06-06 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
NL1013049A1 (nl) 2000-03-21
NO994463D0 (no) 1999-09-15
KR20000023206A (ko) 2000-04-25
NL1013049C2 (nl) 2002-01-11
SG76631A1 (en) 2000-11-21
FR2783426A1 (fr) 2000-03-24
ES2155802A1 (es) 2001-05-16
ITTO990784A1 (it) 2001-03-14
DE19944695A1 (de) 2000-03-30
IL131722A0 (en) 2001-03-19
BE1012725A5 (fr) 2001-02-06
GB2341800A (en) 2000-03-29
SE0100195D0 (sv) 2001-01-24
GB9920710D0 (en) 1999-11-03
SE0100195L (sv) 2001-01-24
CN1255376A (zh) 2000-06-07
ES2155802B1 (es) 2001-12-01
JP2000159682A (ja) 2000-06-13
NO994463L (no) 2000-03-20
NL1019705A1 (nl) 2002-01-29
IT1307267B1 (it) 2001-10-30
DK199901235A (da) 2000-03-18
IS5183A (is) 2000-03-17
AU4486299A (en) 2000-03-30
ITTO990784A0 (it) 1999-09-14
NL1019705C2 (nl) 2002-03-26
ID23150A (id) 2000-03-23
FR2788697A1 (fr) 2000-07-28
SE9903307D0 (sv) 1999-09-16
SE9903307L (sv) 2000-03-18
GB9921387D0 (en) 1999-11-10

Similar Documents

Publication Publication Date Title
KR900006885B1 (ko) 활성산소 억제 조성물 및 이의 제조방법
CA2282234A1 (en) Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug
US6440448B1 (en) Food supplement/herbal composition for health enhancement
KR20120107557A (ko) 엽록소가 함유된 미강의 발효추출물 및 그 제조방법
CN101815524A (zh) 基于海巴戟天叶汁和叶提取物的制剂
KR102265592B1 (ko) 5-아미노레불린산 수화염화물을 포함하는 조성물
CN1065433C (zh) 油性制剂及其制备方法
KR100838113B1 (ko) 식용금분이 함유된 상황버섯 재배방법 및 그 상황버섯
Hassan et al. Wheat Grass (Triticum aestivum L.) Benefits Health in a Pandemic Scenario
JP2001199892A (ja) アミグダリン含有物の抗腫瘍活性強化方法、抗腫瘍活性強化アミグダリン含有物を含む組成物、アミグダリン含有物処理の抗腫瘍有効性評価方法、およびアミグダリン含有物の抗腫瘍有効性評価方法
JPH05146272A (ja) 植物抗酸化組成物
CN102308989B (zh) 一种具有保健功能的红蚁、葡萄、蜂胶提取物的组合物
JP2021031440A (ja) 天然物由来の低分子抗酸化性化合物を含有する活性酸素除去剤と、マクロファージとリンパ球を増強するために用いられる天然物由来の免疫活性化剤とを有する抗腫瘍剤セット
WO2002064153A1 (en) Ixeris dendata extracting having biological activities and immune enhancing effects
KR101934811B1 (ko) 복합 생약 추출물을 포함하는 혈행 개선용 제제
JP2003171306A (ja) 生理活性組成物及びその製造方法
KR20060098144A (ko) 몰로키아와 홍삼을 함유한 건강식품 조성물
MXPA01008808A (es) Proceso para la obtencion del suplemento alimenticio para ayuda contra el cancer.

Legal Events

Date Code Title Description
FZDE Discontinued